In the tumor microenvironment, MMP9 degrades type I collagen, releasing fragments that engage the inhibitory receptor leukocyte-associated immunoglobulin-like receptor-1 (Lair-1) on T cells and attenuate TCR signaling [36]. The gene discussed is MMP9; the disease is neoplasm.